nach oben

Erschienen in:

25.04.2024 | Research Article

Hypotensive episodes at 24-h ambulatory blood pressure monitoring predict adverse outcomes in Parkinson’s disease

verfasst von: Fabrizio Vallelonga, Matteo Valente, Marta Maria Tangari, Anna Covolo, Valeria Milazzo, Cristina Di Stefano, Gabriele Sobrero, Marta Giudici, Alberto Milan, Franco Veglio, Leonardo Lopiano, Simona Maule, Alberto Romagnolo

Erschienen in: Clinical Autonomic Research | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Neurogenic orthostatic hypotension (nOH) is a frequent nonmotor feature of Parkinson’s disease (PD), associated with adverse outcomes. Recently, 24-h ambulatory blood pressure monitoring (ABPM) showed good accuracy in diagnosing nOH. This study aims at evaluating the prognostic role of ABPM-hypotensive episodes in predicting PD disability milestones and mortality and comparing it to the well-defined prognostic role of bedside nOH.

Methods

Patients with PD who underwent ABPM from January 2012 to December 2014 were retrospectively enrolled and assessed for the development of falls, fractures, dementia, bed/wheelchair confinement, hospitalization, and mortality, during an up-to-10-year follow-up. Significant ABPM-hypotensive episodes were identified when greater than or equal to two episodes of systolic BP drop ≥ 15 mmHg (compared with the average 24 h) were recorded during the awakening-to-lunch period.

Results

A total of 99 patients (74% male, age 64.0 ± 10.1 years, and PD duration 6.4 ± 4.0 years) were enrolled. At baseline, 38.4% of patients had ABPM-hypotensive episodes and 46.5% had bedside nOH.

On Kaplan–Meier analysis, patients with ABPM-hypotensive episodes showed earlier onset of falls (p = 0.001), fractures (p = 0.004), hospitalizations (p = 0.009), bed/wheelchair confinement (p = 0.032), dementia (p = 0.001), and shorter survival (8.0 versus 9.5 years; p = 0.009). At Cox regression analysis (adjusted for age, disease duration, Charlson Comorbidity Index, and Hoehn and Yahr stage) a significant association was confirmed between ABPM-hypotensive episodes and falls [odds ratio (OR) 3.626; p = 0.001), hospitalizations (OR 2.016; p = 0.038), and dementia (OR 2.926; p = 0.008), while bedside nOH was only associated with falls (OR 2.022; p = 0.039) and dementia (OR 1.908; p = 0.048).

Conclusions

The presence of at least two ABPM-hypotensive episodes independently predicted the development of falls, dementia, and hospitalization, showing a stronger prognostic value than the simple bedside assessment.

Merola A, Sawyer RP, Artusi CA et al (2018) Orthostatic hypotension in Parkinson disease: impact on health care utilization. Parkinsonism Relat Disord 47:45–49. https://doi.org/10.1016/j.parkreldis.2017.11.344CrossRefPubMed

Velseboer DC, de Haan RJ, Wieling W et al (2011) Prevalence of orthostatic hypotension in Parkinson’s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 17:724–729. https://doi.org/10.1016/j.parkreldis.2011.04.016CrossRefPubMedPubMedCentral

Palma J-A, Gomez-Esteban JC, Norcliffe-Kaufmann L et al (2015) Orthostatic hypotension in Parkinson disease: how much you fall or how low you go? Mov Disord 30:639–645. https://doi.org/10.1002/mds.26079CrossRefPubMedPubMedCentral

Ricci F, Fedorowski A, Radico F et al (2015) Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies. Eur Heart J 36:1609–1617. https://doi.org/10.1093/eurheartj/ehv093CrossRefPubMed

Romagnolo A, Zibetti M, Merola A et al (2019) Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study. J Neurol 266:85–91. https://doi.org/10.1007/s00415-018-9104-4CrossRefPubMed

Longardner K, Merola A, Litvan I et al (2022) Differential impact of individual autonomic domains on clinical outcomes in Parkinson’s disease. J Neurol 269:5510–5520. https://doi.org/10.1007/s00415-022-11221-9CrossRefPubMedPubMedCentral

Pilotto A, Romagnolo A, Scalvini A et al (2021) Association of orthostatic hypotension with cerebral atrophy in patients with Lewy body disorders. Neurology 97:e814–e824. https://doi.org/10.1212/WNL.0000000000012342CrossRefPubMedPubMedCentral

McDonald C, Newton JL, Burn DJ (2016) Orthostatic hypotension and cognitive impairment in Parkinson’s disease: causation or association? Mov Disord 31:937–946. https://doi.org/10.1002/mds.26632CrossRefPubMed

Udow SJ, Robertson AD, MacIntosh BJ et al (2016) “Under pressure”: is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies? J Neurol Neurosurg Psychiatry 87:1311–1321. https://doi.org/10.1136/jnnp-2016-314123CrossRefPubMed

10.

Freeman R, Wieling W, Axelrod FB et al (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res Off J Clin Auton Res Soc 21:69–72. https://doi.org/10.1007/s10286-011-0119-5CrossRef

11.

Wieling W, Kaufmann H, Claydon VE et al (2022) Diagnosis and treatment of orthostatic hypotension. Lancet Neurol 21:735–746. https://doi.org/10.1016/S1474-4422(22)00169-7CrossRefPubMedPubMedCentral

12.

Norcliffe-Kaufmann L, Kaufmann H (2014) Is ambulatory blood pressure monitoring useful in patients with chronic autonomic failure? Clin Auton Res Off J Clin Auton Res Soc 24:189–192. https://doi.org/10.1007/s10286-014-0229-yCrossRef

13.

Belmin J, Abderrhamane M, Medjahed S et al (2000) Variability of blood pressure response to orthostatism and reproducibility of the diagnosis of orthostatic hypotension in elderly subjects. J Gerontol A Biol Sci Med Sci 55:M667–M671. https://doi.org/10.1093/gerona/55.11.m667CrossRefPubMed

14.

Vara-González L, Arauzo Alonso S, González Fernández RM et al (2006) Reproducibility of postural changes of blood pressure in hypertensive elderly patients in primary care. Blood Press Monit 11:17–20. https://doi.org/10.1097/01.mbp.0000189786.59994.fbCrossRefPubMed

15.

Ward C, Kenny RA (1996) Reproducibility of orthostatic hypotension in symptomatic elderly. Am J Med 100:418–422. https://doi.org/10.1016/S0002-9343(97)89517-4CrossRefPubMed

16.

Parati G, Stergiou G, O’Brien E et al (2014) European society of hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 32:1359–1366. https://doi.org/10.1097/HJH.0000000000000221CrossRefPubMed

17.

Milazzo V, Di Stefano C, Vallelonga F et al (2018) Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease. Park Relat Disord 56:82–87. https://doi.org/10.1016/j.parkreldis.2018.06.032CrossRef

18.

Vallelonga F, Sobrero G, Giudici M et al (2021) Screening indexes for cardiovascular autonomic failure in Parkinson’s disease. J Neurol Sci 428:117571. https://doi.org/10.1016/j.jns.2021.117571CrossRefPubMed

19.

Vallelonga F, Romagnolo A, Merola A et al (2019) Detection of orthostatic hypotension with ambulatory blood pressure monitoring in parkinson’s disease. Hypertens Res 42:1552–1560. https://doi.org/10.1038/s41440-019-0267-xCrossRefPubMed

20.

Juraschek SP, Taylor AA, Wright JTJ et al (2020) Orthostatic hypotension, cardiovascular outcomes, and adverse events: results from SPRINT. Hypertens (Dallas, Tex 1979) 75:660–667. https://doi.org/10.1161/HYPERTENSIONAHA.119.14309CrossRef

21.

Gibb WRG (1988) Accuracy in the clinical diagnosis of parkinsonian syndromes. Postgrad Med J 64:345–351. https://doi.org/10.1136/PGMJ.64.751.345CrossRefPubMedPubMedCentral

22.

Dineen J, Freeman R (2015) Autonomic neuropathy. Semin Neurol 35:458–468. https://doi.org/10.1055/s-0035-1558983CrossRefPubMed

23.

Jankovic J, McDermott M, Carter J et al (1990) Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study. Group Neurol 40:1529–1534. https://doi.org/10.1212/wnl.40.10.1529CrossRef

24.

Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383. https://doi.org/10.1016/0021-9681(87)90171-8CrossRefPubMed

25.

Kaufmann H, Malamut R, Norcliffe-Kaufmann L et al (2012) The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale. Clin Auton Res Off J Clin Auton Res Soc 22:79–90. https://doi.org/10.1007/s10286-011-0146-2CrossRef

26.

Norcliffe-Kaufmann L, Kaufmann H, Palma JA et al (2018) Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Ann Neurol 83:522–531. https://doi.org/10.1002/ana.25170CrossRefPubMedPubMedCentral

27.

Jansen RW, Lipsitz LA (1995) Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med 122:286–295. https://doi.org/10.7326/0003-4819-122-4-199502150-00009CrossRefPubMed

28.

Dalrymple-Alford JC, MacAskill MR, Nakas CT et al (2010) The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 75:1717–1725. https://doi.org/10.1212/WNL.0b013e3181fc29c9CrossRefPubMed

29.

(2013) Diagnostic and statistical manual of mental disorders: DSM-5^TM, 5th edn. American Psychiatric Publishing, Inc., Arlington

30.

Ganz DA, Latham NK (2020) Prevention of falls in community-dwelling older adults. N Engl J Med 382:734–743. https://doi.org/10.1056/NEJMcp1903252CrossRefPubMed

31.

Vallelonga F, Maule S (2019) Diagnostic and therapeutical management of supine hypertension in autonomic failure: a review of the literature. J Hypertens 37:1102–1111. https://doi.org/10.1097/HJH.0000000000002008CrossRefPubMed

32.

Merola A, Romagnolo A, Rosso M et al (2016) Orthostatic hypotension in Parkinson’s disease: does it matter if asymptomatic? Parkinsonism Relat Disord 33:65–71. https://doi.org/10.1016/j.parkreldis.2016.09.013CrossRefPubMed

33.

Cremer A, Soumaré A, Berr C et al (2017) Orthostatic hypotension and risk of incident dementia: results from a 12-year follow-up of the three-city study cohort. Hypertens (Dallas, Tex 1979) 70:44–49. https://doi.org/10.1161/HYPERTENSIONAHA.117.09048CrossRef

34.

Min M, Shi T, Sun C et al (2018) The association between orthostatic hypotension and dementia: a meta-analysis of prospective cohort studies. Int J Geriatr Psychiatry 33:1541–1547. https://doi.org/10.1002/gps.4964CrossRefPubMed

35.

Allan LM, Ballard CG, Allen J et al (2007) Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry 78:671–677. https://doi.org/10.1136/jnnp.2006.102343CrossRefPubMed

36.

Robertson AD, Udow SJ, Espay AJ et al (2019) Orthostatic hypotension and dementia incidence: links and implications. Neuropsychiatr Dis Treat 15:2181–2194. https://doi.org/10.2147/NDT.S182123CrossRefPubMedPubMedCentral

37.

Pilotto A, Romagnolo A, Tuazon JA et al (2019) Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in α-synucleinopathies. J Neurol Neurosurg Psychiatry 90:1257–1263. https://doi.org/10.1136/jnnp-2019-320846CrossRefPubMed

38.

Fereshtehnejad S-M, Romenets SR, Anang JBM et al (2015) New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol 72:863–873. https://doi.org/10.1001/jamaneurol.2015.0703CrossRefPubMed

39.

Robertson AD, Messner MA, Shirzadi Z et al (2016) Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders. Parkinsonism Relat Disord 22:80–86. https://doi.org/10.1016/j.parkreldis.2015.11.019CrossRefPubMed

40.

Palma JA, Redel-Traub G, Porciuncula A et al (2020) The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension. Park Relat Disord 75:97–104. https://doi.org/10.1016/j.parkreldis.2020.04.011CrossRef

41.

Chen H, Xu E, Zhou F et al (2022) Impaired dynamic cerebral autoregulation: a potential mechanism of orthostatic hypotension and dementia in Parkinson’s disease. Front Aging Neurosci 14:927009. https://doi.org/10.3389/fnagi.2022.927009CrossRefPubMedPubMedCentral

42.

Barrio IR, Miki Y, Jaunmuktane ZT et al (2022) Association between orthostatic hypotension and dementia in patients with Parkinson disease and multiple system atrophy. Neurology. https://doi.org/10.1212/WNL.0000000000201659CrossRef

43.

Asmuje NF, Mat S, Myint PK, Tan MP (2022) Blood pressure variability and cognitive function: a scoping review. Curr Hypertens Rep 24:375–383. https://doi.org/10.1007/s11906-022-01200-wCrossRefPubMed

44.

Shibao C, Grijalva CG, Raj SR et al (2007) Orthostatic hypotension-related hospitalizations in the United States. Am J Med 120:975–980. https://doi.org/10.1016/j.amjmed.2007.05.009CrossRefPubMed

45.

Grijalva CG, Biaggioni I, Griffin MR, Shibao CA (2017) Fludrocortisone is associated with a higher risk of all-cause hospitalizations compared with midodrine in patients with orthostatic hypotension. J Am Heart Assoc. https://doi.org/10.1161/JAHA.117.006848CrossRefPubMedPubMedCentral

46.

Feldstein C, Weder AB (2012) Orthostatic hypotension: a common, serious and underrecognized problem in hospitalized patients. J Am Soc Hypertens 6:27–39. https://doi.org/10.1016/j.jash.2011.08.008CrossRefPubMed

47.

Finucane C, O’Connell MDL, Donoghue O et al (2017) Impaired orthostatic blood pressure recovery is associated with unexplained and injurious falls. J Am Geriatr Soc 65:474–482. https://doi.org/10.1111/jgs.14563CrossRefPubMed

48.

Nakamura T, Suzuki M, Ueda M et al (2020) Impact of orthostatic hypotension on wheelchair use in patients with Parkinson’s disease. J Neural Transm 127:379–383. https://doi.org/10.1007/s00702-019-02127-4CrossRefPubMed

49.

Koo HY, Bin CE, Kong SH et al (2023) Fracture risk in Parkinson’s disease according to its severity and duration. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 34:81–89. https://doi.org/10.1007/s00198-022-06562-0CrossRef

50.

De Pablo-Fernández E, Lees AJ, Holton JL, Warner TT (2019) Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease. JAMA Neurol 76:470–479. https://doi.org/10.1001/jamaneurol.2018.4377CrossRefPubMedPubMedCentral

51.

Zhang L, Hou Y, Gu X et al (2023) Prediction of early-wheelchair dependence in multiple system atrophy based on machine learning algorithm: a prospective cohort study. Clin Park Relat Disord 8:100183. https://doi.org/10.1016/j.prdoa.2023.100183CrossRefPubMedPubMedCentral

52.

De Pablo-Fernandez E, Tur C, Revesz T et al (2017) Association of autonomic dysfunction with disease progression and survival in Parkinson disease. JAMA Neurol 74:970–976. https://doi.org/10.1001/jamaneurol.2017.1125CrossRefPubMedPubMedCentral

53.

Goldstein DS, Holmes C, Sharabi Y, Wu T (2015) Survival in synucleinopathies: a prospective cohort study. Neurology 85:1554–1561. https://doi.org/10.1212/WNL.0000000000002086CrossRefPubMedPubMedCentral

Titel: Hypotensive episodes at 24-h ambulatory blood pressure monitoring predict adverse outcomes in Parkinson’s disease
verfasst von: Fabrizio Vallelonga
Matteo Valente
Marta Maria Tangari
Anna Covolo
Valeria Milazzo
Cristina Di Stefano
Gabriele Sobrero
Marta Giudici
Alberto Milan
Franco Veglio
Leonardo Lopiano
Simona Maule
Alberto Romagnolo
Publikationsdatum: 25.04.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Autonomic Research / Ausgabe 2/2024
Print ISSN: 0959-9851
Elektronische ISSN: 1619-1560
DOI: https://doi.org/10.1007/s10286-024-01030-7

Neu in den Fachgebieten Neurologie und Psychiatrie

Blutdrucksenkung schon im Rettungswagen bei akutem Schlaganfall?

31.05.2024 Apoplex Nachrichten

Der optimale Ansatz für die Blutdruckkontrolle bei Patientinnen und Patienten mit akutem Schlaganfall ist noch nicht gefunden. Ob sich eine frühzeitige Therapie der Hypertonie noch während des Transports in die Klinik lohnt, hat jetzt eine Studie aus China untersucht.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Hypotensive episodes at 24-h ambulatory blood pressure monitoring predict adverse outcomes in Parkinson’s disease

Abstract

Purpose

Methods

Results

Conclusions

Neu in den Fachgebieten Neurologie und Psychiatrie

Blutdrucksenkung schon im Rettungswagen bei akutem Schlaganfall?

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

Schutz der Synapsen bei Alzheimer

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2024

Is it time to move beyond blood pressure and heart rate during head-up tilt testing?

A case report illustrating the ‘hypotensive twilight zone’ in Parkinson’s disease; an under-recognised presentation of orthostatic hypotension

Sex-related differences in the clinical presentation of multiple system atrophy

Supine hypertension is longitudinally associated with verbal memory decline in Parkinson disease

The effect of hyperoxia on muscle sympathetic nerve activity: a systematic review and meta-analysis

Sympathetic dysfunction as an early indicator of autonomic involvement in Parkinson’s disease

Neu in den Fachgebieten Neurologie und Psychiatrie

Blutdrucksenkung schon im Rettungswagen bei akutem Schlaganfall?

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

Schutz der Synapsen bei Alzheimer

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid